Estrategias Combinadas en Inmunoterapia Traslacional
ITC
Centro Nacional de Investigaciones Cardiovasculares Carlos III
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Investigaciones Cardiovasculares Carlos III (8)
2022
-
Depletion of Conventional Type-1 Dendritic Cells in Established Tumors Suppresses Immunotherapy Efficacy
Cancer research, Vol. 82, Núm. 23, pp. 4373-4385
2021
-
DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type i conventional dendritic cells
Journal for ImmunoTherapy of Cancer, Vol. 9, Núm. 5
2018
-
Erratum: Author Correction: Conventional CD4+ T cells present bacterial antigens to induce cytotoxic and memory CD8+ T cell responses (Nature communications (2017) 8 1 (1591))
Nature communications
-
Mitochondrial morphological and functional reprogramming following CD137 (4-1BB) Costimulation
Cancer Immunology Research, Vol. 6, Núm. 7, pp. 798-811
2017
-
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
Annals of Oncology, Vol. 28, pp. xii44-xii55
-
Conventional CD4+ T cells present bacterial antigens to induce cytotoxic and memory CD8+ T cell responses
Nature Communications, Vol. 8, Núm. 1
2016
-
First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases
Science Translational Medicine, Vol. 8, Núm. 370
2011
-
Agonist anti-CD137 mAb act on tumor endothelial cells to enhance recruitment of activated T lymphocytes
Cancer Research, Vol. 71, Núm. 3, pp. 801-811